A Phase 1b Study to Assess the Safety, Tolerability, Pharmacokinetics, and Exploratory Efficacy of Intravitreal OLN324
Public ClinicalTrials.gov record NCT07484074. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1b Study to Assess the Safety, Tolerability, Pharmacokinetics, and Exploratory Efficacy of Two Different Formulations of Intravitreal OLN324 in Adult Participants With Either Neovascular (Wet) Age-related Macular Degeneration (nAMD) or Diabetic Macular Edema (DME)
Study identification
- NCT ID
- NCT07484074
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Ollin Biosciences, Inc.
- Industry
- Enrollment
- 164 participants
Conditions and interventions
Interventions
- Faricimab Drug
- OLN324 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 11, 2025
- Primary completion
- Oct 9, 2025
- Completion
- Dec 8, 2025
- Last update posted
- Mar 18, 2026
2025
United States locations
- U.S. sites
- 29
- U.S. states
- 13
- U.S. cities
- 29
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Phoenix, AZ | Phoenix | Arizona | 85016 | — |
| Glendale, CA | Glendale | California | 91204 | — |
| Pasadena, CA | Pasadena | California | 91107 | — |
| Sacramento, CA | Sacramento | California | 95825 | — |
| Walnut Creek, CA | Walnut Creek | California | 94598 | — |
| Waterford, CT | Waterford | Connecticut | 06385 | — |
| Fort Myers, FL | Fort Myers | Florida | 33912 | — |
| Saint Petersburg, FL | St. Petersburg | Florida | 33711 | — |
| Winter Haven, FL | Winter Haven | Florida | 33880 | — |
| Oak Forest, IL | Oak Forest | Illinois | 60452 | — |
| Hagerstown, MD | Hagerstown | Maryland | 21740 | — |
| Grand Rapids, MI | Grand Rapids | Michigan | 49546 | — |
| Reno, NV | Reno | Nevada | 89502 | — |
| Wake Forest, NC | Wake Forest | North Carolina | 27587 | — |
| Tulsa, OK | Tulsa | Oklahoma | 74114 | — |
| Springfield, OR | Springfield | Oregon | 97477 | — |
| Germantown, TN | Germantown | Tennessee | 38138 | — |
| Abilene, TX | Abilene | Texas | 79606 | — |
| Arlington, TX | Arlington | Texas | 76012 | — |
| Austin, TX | Austin | Texas | 78705 | — |
| Bellaire, TX | Bellaire | Texas | 77401 | — |
| Dallas, TX | Dallas | Texas | 75231 | — |
| Katy, TX | Katy | Texas | 77494 | — |
| Plano, TX | Plano | Texas | 75075 | — |
| Round Rock, TX | Round Rock | Texas | 78681 | — |
| San Antonio, TX | San Antonio | Texas | 78240 | — |
| San Marcos, TX | San Marcos | Texas | 78666 | — |
| Schertz, TX | Schertz | Texas | 78154 | — |
| The Woodlands, TX | The Woodlands | Texas | 77384 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07484074, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 18, 2026 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07484074 live on ClinicalTrials.gov.